Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.

EfficientNet improves accuracy in diagnosing hair loss stages.

O'Tar T. Norwood was a key figure in creating a system to classify male baldness and founding hair restoration societies.

No current system perfectly classifies male-pattern hair loss, indicating a need for a new system for better diagnosis and treatment.

Dr. Muhammad Ahmad created a simpler system to better describe male pattern hair loss.

The BASP classification is a detailed system for categorizing hair loss in both men and women, but it may be complex for beginners and not fully suitable for grading female hair loss.

A hybrid model using traditional methods, trichoscopy, and AI improves hair loss assessment.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

The document explains how hair loss patterns in men and women, known as Androgenetic alopecia, are classified using the Hamilton-Norwood system for men and the Ludwig grade system for women.

Male pattern hair loss is mainly caused by genetics and hormones, especially DHT.

The document explains how hair loss in men and women, known as Androgenetic alopecia, is categorized using the Hamilton-Norwood system for men and the Ludwig grade system for women.

Dr. Bernard Cohen created a new system to classify hair loss using numbers and a detailed scalp map.

Injecting platelet-rich plasma is a safe and effective way to treat hair loss.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

Male pattern baldness affects 38.52% of Asian men in Bangkok, increasing with age and influenced by genes and environment.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Hair transplantation has evolved to refined techniques like FUE and FUT, with Finasteride and Minoxidil as the only other proven treatments for hair loss.

Male pattern baldness may predict prostate cancer risk.

Hair transplantation is a treatment for hair loss mainly caused by genetics, with various techniques and potential complications, and results visible after 8-12 months.

Smoking 20+ cigarettes daily increases the risk of severe hair loss in men.

Hair transplantation is a surgical procedure to move hair to bald areas, requires good donor hair, and results show in about a year.

FUE hair transplants have improved to give more natural results with less scarring and pain.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

Receding hairlines in men are uneven, with the right side larger than the left.

Androgenic alopecia (AA) in Indian women is rarely reported, with varying severity and patterns, and hair pull tests and trichograms help understand it better.

Epigenetic differences affect hair loss in identical Japanese male twins.

Balding in men worsens with age.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.